NCT03772925 2026-03-03Pevonedistat and Belinostat in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic SyndromeNational Cancer Institute (NCI)Phase 1 Terminated18 enrolled 19 charts